ArticleJapanese journal of radiology2018
Radiofrequency ablation versus cryoablation for T1b renal cell carcinoma: a multi-center study.
Article in Japanese journal of radiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 54 citations in OpenAlex.
- Pooled it
- Organ-sparing procedures in GU cancer: part 1-organ-sparing procedures in renal and adrenal tumors: a systematic review.International urology and nephrology · 2019Pooled it
- Percutaneous Cryoablation of Clinical T1b Renal Tumors: A Tertiary Cancer Center Experience.Cardiovascular and interventional radiology · 2026Observational
- Percutaneous ablation of T1b renal tumors: a review.Cancer imaging : the official publication of the International Cancer Imaging Society · 2026Review
- Image-guided percutaneous ablative treatments for renal cell carcinoma.European radiology · 2025Review
- Impact of thermal ablation/cryoablation treatment on prognosis among patients with kidney cancer: a SEER database-based cohort study.European journal of medical research · 2025Article
- Percutaneous Image-Guided Ablation of Renal Cancer: Traditional and Emerging Indications, Energy Sources, Techniques, and Future Developments.Medicina (Kaunas, Lithuania) · 2025Review
- Comparing Oncologic Outcomes of Heat-Based Thermal Ablation and Cryoablation in Patients With T1a Renal Cell Carcinoma: A Population-Based Cohort Study From the SEER Database.Korean journal of radiology · 2024Article
- Combining Transarterial Embolization and Percutaneous Cryoablation for Early-Stage Renal Cell Carcinoma: Embolization Materials and Impacts of Tumor Size.Tomography (Ann Arbor, Mich.) · 2024Article
- Percutaneous cryoablation of renal tumours under computed tomography guidance: methodology of the procedure.Polish journal of radiology · 2024Article
- Percutaneous Ablation of T1 Renal Masses: Comparative Local Control and Complications after Radiofrequency and Cryoablation.Diagnostics (Basel, Switzerland) · 2023Article
- A multicenter comparative matched-pair analysis of percutaneous tumor ablation and robotic-assisted partial nephrectomy of T1b renal cell carcinoma (AblatT1b study-UroCCR 80).European radiology · 2023Article
- Efficacy and safety of cryoablation for localized renal tumor as an alternative approach to partial nephrectomy.Frontiers in oncology · 2023Article
- Review
- Comparison of Radiofrequency Ablation Versus Cryoablation For T1 Renal Tumors: An Evidence-Based Analysis of Comparative Outcomes.Frontiers in oncology · 2022Article
- Image-guided percutaneous cryoablation of T1b renal cell carcinomas in patients with comorbidities.Japanese journal of radiology · 2021Article
- Thermal Ablation for Renal Cell Carcinoma: Expert Consensus from the Asian Conference on Tumor Ablation.Korean journal of radiology · 2021Review
- Asian Conference on Tumor Ablation guidelines for renal cell carcinoma.Investigative and clinical urology · 2021Review
- Percutaneous Image-guided Thermal Ablation for Renal Cell Carcinoma.Interventional radiology (Higashimatsuyama-shi (Japan) · 2020Review
- Thermal Ablation of T1a Renal Cell Carcinoma: The Clinical Evidence.Seminars in interventional radiology · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo compare the clinical outcomes between radiofrequency ablation (RFA) and cryoablation for the treatment of clinical T1b (cT1b) renal cell carcinoma (RCC). MATERIALS AND
methodsThe data of 46 patients [(39 men and 7 women, median age; 73 years, range 39-87 years)] were gathered from 3 institutions. RFA and cryoablation were performed on 23 patients each. The median number of ablation needle was 2 (range 1-4) and 4 (range 3-5, p < 0.0001) in RFA and cryoablation, respectively. Technique efficacy defined as coverage of the tumor by ablative zone, adverse events, local tumor progression, and survival were compared between the RFA and cryoablation groups.
resultsThe primary technique efficacy rate was significantly higher in the cryoablation group (96%, 22/23) than in the RFA group (65%, 15/23, P = 0.02). There was no significant difference in the secondary technique efficacy rate after additional RFA and cryoablation [21/23 (91%) vs. 23/23 (100%); P = 0.24]. The incidence of grade 3 or higher adverse events was similar between the 2 groups (P > 0.99). There was no significant difference between local tumor progression rate after RFA and cryoablation [3/21 (14%) vs. 2/23 (9%); P = 0.66]. The 5-year overall survival rates were comparable between RFA and cryoablation (78 vs. 82%; P =0.82).
conclusionOther than primary technique efficacy, the clinical outcomes between RFA and cryoablation were similar in patients with cT1b RCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.